IL6 and rheumatoid arthritis: Sattar et al. suggested markers of systemic inflammation (such as interleukin (IL)-6, IL-1, and tumor necrosis factor (TNF)) have been correlated with an increased risk of cardiovascular death in patients with RA [37].